1.
J Neuroimmunol
; 324: 119-125, 2018 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30269038
RESUMO
Recommended first line treatment in anti-NMDAR encephalitis includes steroids, IVIG, or plasma exchange. However, IVIG is non-reimbursable through Thailand's Universal Health Coverage. This study investigated outcomes from different treatments for anti-NMDAR encephalitis. Nineteen children in three treatments group: steroid alone, IVIG alone, and IVIG and steroid were reviewed. IVIG was administered to 13 (68%) and 6 (32%) only received steroids. Those receiving IVIG treatment with or without steroids had greater improvement in mRS at 6 (pâ¯=â¯0.04) and 12â¯months (pâ¯=â¯0.03). Such findings suggest the benefits of IVIG treatment for this condition despite the higher immediate cost.